Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by F. Do
Crystal Structure of Human Immunodeficiency Virus (HIV) Type 2 Protease in Complex With a Reduced Amide Inhibitor and Comparison With HIV-1 Protease Structures.
Proceedings of the National Academy of Sciences of the United States of America
Multidisciplinary
Related publications
Polymorphism of the Human Immunodeficiency Virus Type 1 (HIV-1) Protease Gene and Response of HIV-1-Infected Patients to a Protease Inhibitor
Journal of Clinical Microbiology
Microbiology
Activities of the Human Immunodeficiency Virus Type 1 (HIV-1) Protease Inhibitor Nelfinavir Mesylate in Combination With Reverse Transcriptase and Protease Inhibitors Against Acute HIV-1 Infection in Vitro.
Antimicrobial Agents and Chemotherapy
Infectious Diseases
Pharmacology
Intracellular Expression of Human Immunodeficiency Virus Type 1 (HIV-1) Protease Variants Inhibits Replication of Wild-Type and Protease Inhibitor-Resistant HIV-1 Strains in Human T-Cell Lines.
Journal of Virology
Insect Science
Immunology
Microbiology
Virology
Crystal Structure of a Complex of HIV-1 Protease With a Dihydroxyethylene-Containing Inhibitor: Comparisons With Molecular Modeling
Protein Science
Biochemistry
Medicine
Molecular Biology
In Vitro Selection and Characterization of Human Immunodeficiency Virus Type 1 (HIV-1) Isolates With Reduced Sensitivity to Hydroxyethylamino Sulfonamide Inhibitors of HIV-1 Aspartyl Protease.
Journal of Virology
Insect Science
Immunology
Microbiology
Virology
FR901724, a Novel Anti-Human Immunodeficiency Virus (HIV) Peptide Produced by Streptomyces, Shows Synergistic Antiviral Activities With HIV Protease Inhibitor and 2',3'-Dideoxynucleosides.
Biological and Pharmaceutical Bulletin
Medicine
Pharmacology
Pharmaceutical Science
Mutation Patterns and Structural Correlates in Human Immunodeficiency Virus Type 1 Protease Following Different Protease Inhibitor Treatments
Journal of Virology
Insect Science
Immunology
Microbiology
Virology
Defining the Level of Human Immunodeficiency Virus Type 1 (HIV-1) Protease Activity Required for HIV-1 Particle Maturation and Infectivity.
Journal of Virology
Insect Science
Immunology
Microbiology
Virology
Safety and Pharmacokinetics of Amprenavir (141W94), a Human Immunodeficiency Virus (HIV) Type 1 Protease Inhibitor, Following Oral Administration of Single Doses to HIV-Infected Adults
Antimicrobial Agents and Chemotherapy
Infectious Diseases
Pharmacology